IMPLANON's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9757552 | ORGANON | Applicator for inserting an implant |
Jul, 2030
(6 years from now) | |
Implanon is owned by Organon.
Implanon contains Etonogestrel.
Implanon has a total of 1 drug patent out of which 0 drug patents have expired.
Implanon was authorised for market use on 17 July, 2006.
Implanon is available in implant;implantation dosage forms.
Implanon can be used as prevention of pregnancy.
The generics of Implanon are possible to be released after 28 July, 2030.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Product(NP) | May 31, 2014 |
Drugs and Companies using ETONOGESTREL ingredient
Market Authorisation Date: 17 July, 2006
Treatment: Prevention of pregnancy
Dosage: IMPLANT;IMPLANTATION
More Information on Dosage
IMPLANON family patents
